- CA$952.72m
- CA$1.16bn
- $60.61m
- 27
- 46
- 62
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 6 M |
Source: | ARS | ARS | ARS | ARS | 10-KT |
Standards: | IFRS | IFRS | IFRS | IFRS | USG |
Status: | fx Final | fx Final | fx Final | fx Final | Final |
Revenue | |||||
Total Revenue | 61.8 | 30.4 | 139 | 116 | 60.6 |
Cost of Revenue | |||||
Gross Profit | 2.63 | -15.1 | 70.8 | -19.2 | 26.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 57.5 | 25.9 | 99.8 | 261 | 50.3 |
Operating Profit | 4.36 | 4.49 | 38.9 | -145 | 10.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.61 | 2.98 | -53.5 | -179 | 5.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.61 | 14.2 | -58 | -187 | 6.21 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.61 | 14.2 | -58 | -187 | 6.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.61 | 14.2 | -58 | -187 | 6.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.084 | 0.343 | -2.17 | -3.39 | -0.024 |
Dividends per Share |